Keidai Ishikawa

536 citations
23 papers · 426 indexed · h-index 10
Topics
Lung Cancer Diagnosis and Treatment (5 papers)Pleural and Pulmonary Diseases (4 papers)Soft tissue tumor case studies (3 papers)
Partner nations
Japan

In The Last Decade

Keidai Ishikawa

20 papers receiving 420 citations

Peers

Keidai Ishikawa
Comparison fields: 5 of 47
  • Molecular Biology 246
  • Pulmonary and Respiratory Medicine 157
  • Oncology 152
  • Cancer Research 103
  • Cell Biology 78
Replace Riitta Mäkitaro with:
Riitta Mäkitaro Finland
Cara Dubyk United States
Nina Waldburger Germany
C. Ormazábal Spain
Amaury G. Dumont United States
Susana Martínez-Canarias Spain
Meleah Cameron United States
Jingtong Zhai China
Hideki Yoshikawa Japan
Wen Min Lau United States
Keidai Ishikawa relative to Riitta Mäkitaro Finland Riitta Mäkitaro's profile →
Citations per field
00.5×1.5×2.2×
Riitta Mäkitaro · 1×
Citations per year

Countries citing papers authored by Keidai Ishikawa

Since Specialization
Citations

This map shows the geographic impact of Keidai Ishikawa's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Keidai Ishikawa with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Keidai Ishikawa more than expected).

Fields of papers citing papers by Keidai Ishikawa

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Keidai Ishikawa. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Keidai Ishikawa. The network helps show where Keidai Ishikawa may publish in the future.

Co-authorship network of co-authors of Keidai Ishikawa

This figure shows the co-authorship network connecting the top 25 collaborators of Keidai Ishikawa. A scholar is included among the top collaborators of Keidai Ishikawa based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Keidai Ishikawa. Keidai Ishikawa is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
#WorkIndexed citations
1 1
2 21
3 13
4 7
5 3
6 13
7 134
8 30
9 11
10 11
11 8
12 74
13 1
14 55
15 9
16 26
17 0
18 1
19 0
20 4

About Keidai Ishikawa

Keidai Ishikawa is a scholar working on Pulmonary and Respiratory Medicine, Oncology and Rheumatology, having authored 23 papers that have together received 426 indexed citations. Recurring topics across this work include Lung Cancer Diagnosis and Treatment (5 papers), Pleural and Pulmonary Diseases (4 papers) and Soft tissue tumor case studies (3 papers). The work is most often cited by research in Cancer Research (103 citations), Oncology (152 citations) and Pulmonary and Respiratory Medicine (157 citations). Keidai Ishikawa has collaborated with scholars based in Japan. Frequent co-authors include Tatsuya Kato, Mitsuhito Kaji, Masato Aragaki, Masaaki Sato, Yataro Daigo, Satoshi Kondo, Kenzo Okamoto, Tomoo Itoh, Satoshi Hirano and Masaaki Sato. Their work appears in journals such as Cancer, Lung Cancer and Journal of Surgical Oncology.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026